Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all
Gil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
The AAPS Journal
|
March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report
Sophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
The American Journal of Gastroenterology
|
January 9, 2025
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial
Jessica R Allegretti, Adam S Cheifetz, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
Alexander Abadir, Angela Troia, Hyder Said, et al.
Annals of Gastroenterology
|
May 21, 2026
Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel disease
Loren G Rabinowitz, Tina Deyhim, Joyce Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results
Gil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all
Gil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
The AAPS Journal
|
March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report
Sophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
The American Journal of Gastroenterology
|
January 9, 2025
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial
Jessica R Allegretti, Adam S Cheifetz, Parambir S Dulai, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
Alexander Abadir, Angela Troia, Hyder Said, et al.
Annals of Gastroenterology
|
May 21, 2026
Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel disease
Loren G Rabinowitz, Tina Deyhim, Joyce Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results
Gil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Page
of 21